AI Bias Analysis
4 models · Takes ~15 seconds
The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.
Source
Stat News
Opens original article in a new tab
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall under mandatory reporting requirements.
HaloMD is a middleman that became the top filer of out-of-network billing disputes on behalf of medical providers.
(MedPage Today) -- Persistence in appealing denied health insurance claims resulted in overturned decisions between 30% and 78% percent of the time, when the case reached independent review organizations (IROs), an analysis of completed external...
(MedPage Today) -- The FDA said it reminded more than 2,000 pharmaceutical companies and researchers about legal requirements to publish clinical trial data, warning that a publication preference for positive trials could be skewing the available...
